EDITAS MEDICINE INC.

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

12 8月 2024 09:46:03 条件 NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

09 8月 2024 10:12:14 条件 NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

07 8月 2024 11:59:49 条件 NetDania Notify

Editas Medicine Announces Second Quarter 2024 Results and Business Updates

07 8月 2024 07:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

05 8月 2024 09:45:15 条件 NetDania Notify

Editas Medicine Announces Second Quarter 2024 Results Conference Call and Corporate Update

31 7月 2024 07:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

02 7月 2024 09:45:34 条件 NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

01 7月 2024 14:01:29 条件 NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

28 6月 2024 09:47:12 条件 NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

27 6月 2024 09:45:34 条件 NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

26 6月 2024 10:52:15 条件 NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

17 6月 2024 10:19:53 条件 NetDania Notify

Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association (EHA) Annual Congress

14 6月 2024 03:01:00 条件 Nasdaq GlobeNewswire

Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patients with Transfusion-dependent Beta Thalassemia, Presented at the European Hematology Association (EHA) Annual Congress

14 6月 2024 03:00:00 条件 Nasdaq GlobeNewswire

Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the European Hematology Association 2024 Congress in June

14 5月 2024 10:00:00 条件 Nasdaq GlobeNewswire

Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting

10 5月 2024 06:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

08 5月 2024 09:49:21 条件 NetDania Notify

Editas Medicine Announces First Quarter 2024 Results and Business Updates

08 5月 2024 07:00:01 条件 Nasdaq GlobeNewswire

Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events

02 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration

01 5月 2024 08:00:01 条件 Nasdaq GlobeNewswire